Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study.

Barten, Markus J; Hirt, Stephan W; Garbade, Jens; Bara, Christoph; Doesch, Andreas O; Knosalla, Christoph; Grinninger, Carola; Stypmann, Jörg; Sieder, Christian; Lehmkuhl, Han B; Porstner, Martina; Schulz, Uwe.
Am J Transplant; 2019 Mar 18.
Artigo em Inglês | MEDLINE | ID: mdl-30884079